Other Resources
Lab Tests Online
Lab Updates / NPG
Services
Genetics Laboratory
Name

Prostate Cancer Screening
Newborn Screening
The Thromboelastogram
Community-acquired MRSA
Diagnostic Utility of Skin Biopsy
Diagnosis of Sepsis
Osteoporosis in Men
Oral Anticoagulant Therapy
Patient with Allergy
Cytology
Role of Vancomycin
Estimated average glucose
Fungitell Option 2
Evolving role of Troponins
Aspirin Resistance
Tumor Markers
Sentinel Lymph Node Biopsy
Swine Influenza
Syphillis
Hereditary Haemochromatosis
Haematological Changes in HIV
Influence of HIV
Drug induced liver injury
Alcohol Abuse
HPV testing in woman
Intravenous immunoglobulins
Death certification
Breat Cancer Month
Therapeutic Plasma Exchange
Bedroom Zoonoses
Dr Suzy Budavari - MBBCh, DTM&H, FCPath (SA)
PATHCHAT NO 13: FUNGITELL OPTION 2
Introduction
Fungitell is a new test offered to detect the presence of certain invasive fungi in the blood. It indicates the presence of these fungi well before they are cultured in clinical specimens, and thus has utility in the EARLY detection of invasive fungal infections.
Candida species are now the 4th most commonly isolated organism in nosocomial bloodstream infections. They are associated with significant morbidity and mortality; attributable mortality has been shown to be as high as 47%. Invasive candidiasis has a non-specific presentation; clinical and radiological signs appear late in the course of the disease (Fig. 1). On the other side of the coin, it is difficult to distinguish colonization from invasive disease in high-risk patients.
Blood cultures are positive in only 50% of cases of invasive candidiasis (some studies have suggested less than 30% of cases). Less than 10% of invasive aspergillosis cases have positive blood cultures. The use of prophylactic fluconazole has decreased the sensitivity of blood cultures even further.
The gold standard has remained the histopathologic demonstration of organisms in tissue (Fig. 2), or the growth of fungi from sterile specimens. This is, however, difficult to apply in the clinical setting.
Delaying anti-fungal therapy has a significant impact on mortality.
What is the Fungitell assay?
This is a colorimetric assay based on the activation of Factor G in the presence of 1,3-B-D-glucan. This then cleaves pnitoaniline from the chromogenic peptide substrate to generate a coloured product which is measured.
Read the full article here.